Hudson Bay Capital Management
DNTH icon

Hudson Bay Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Hudson Bay Capital Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.17M Buy
+109,238
New +$6.33M 0.03% 337
2025
Q3 		– Sell
-115,425
Closed -$2.15M – 1362
2025
Q2 		$2.15M Buy
115,425
+40,425
+54% +$758K 0.01% 774
2025
Q1 		$1.36M Buy
+75,000
New +$1.65M ﹤0.01% 876
2024
Q2 		– Sell
-80,000
Closed -$2.4M – 819
2024
Q1 		$2.4M Buy
+80,000
New +$1.74M 0.01% 427

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Hudson Bay Capital Management's DNTH Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in Dianthus Therapeutics (DNTH) in Q1 2026: 109,238 shares worth $9.17M. The stake represents 0.03% of the portfolio and ranks #337 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in DNTH as recently as Q2 2025.

Hudson Bay Capital Management first reported a position in DNTH in Q1 2024 and has held it in 4 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Hudson Bay Capital Management held 109,238 shares of Dianthus Therapeutics worth $9.17M as of Q1 2026.
  • Dianthus Therapeutics was a new Hudson Bay Capital Management position in Q1 2026.
  • Dianthus Therapeutics made up 0.03% of Hudson Bay Capital Management's portfolio in Q1 2026, its #337 holding.
  • Hudson Bay Capital Management first reported a position in Dianthus Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.